How to buy Grifols S-A stock - 18 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Grifols S-A stock

Own Grifols S-A stock in just a few minutes.

Grifols, S.A is a drug manufacturers-general business based in the US. Grifols S-A shares (GRFS) are listed on the NASDAQ and all prices are listed in US Dollars. Grifols S-A employs 23,668 staff and has a trailing 12-month revenue of around USD$5.3 billion.

How to buy shares in Grifols S-A

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Grifols S-A. Find the stock by name or ticker symbol: GRFS. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Grifols S-A reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Grifols S-A, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Grifols S-A. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Grifols S-A share price

Use our graph to track the performance of GRFS stocks over time.

Grifols S-A shares at a glance

Information last updated 2021-04-16.
52-week rangeUSD$14.81 - USD$21.6186
50-day moving average USD$16.5976
200-day moving average USD$17.8698
Wall St. target priceUSD$27.56
PE ratio 33.9591
Dividend yield USD$0.466 (2.61%)
Earnings per share (TTM) USD$0.538

Buy Grifols S-A shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Grifols S-A stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Grifols S-A under- or over-valued?

Valuing Grifols S-A stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Grifols S-A's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Grifols S-A's P/E ratio

Grifols S-A's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, Grifols S-A shares trade at around 34x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Grifols S-A's PEG ratio

Grifols S-A's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0392. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Grifols S-A's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Grifols S-A's EBITDA

Grifols S-A's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$1.2 billion.

The EBITDA is a measure of a Grifols S-A's overall financial performance and is widely used to measure a its profitability.

Grifols S-A financials

Revenue TTM USD$5.3 billion
Operating margin TTM 18.27%
Gross profit TTM USD$2.3 billion
Return on assets TTM 3.96%
Return on equity TTM 10.45%
Profit margin 11.58%
Book value $3.731
Market capitalisation USD$16.8 billion

TTM: trailing 12 months

Shorting Grifols S-A shares

There are currently 3.8 million Grifols S-A shares held short by investors – that's known as Grifols S-A's "short interest". This figure is 3.2% up from 3.6 million last month.

There are a few different ways that this level of interest in shorting Grifols S-A shares can be evaluated.

Grifols S-A's "short interest ratio" (SIR)

Grifols S-A's "short interest ratio" (SIR) is the quantity of Grifols S-A shares currently shorted divided by the average quantity of Grifols S-A shares traded daily (recently around 1.1 million). Grifols S-A's SIR currently stands at 3.54. In other words for every 100,000 Grifols S-A shares traded daily on the market, roughly 3540 shares are currently held short.

However Grifols S-A's short interest can also be evaluated against the total number of Grifols S-A shares, or, against the total number of tradable Grifols S-A shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Grifols S-A's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Grifols S-A shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Grifols S-A shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Grifols S-A.

Find out more about how you can short Grifols S-A stock.

Grifols S-A share dividends


Dividend payout ratio: 15.88% of net profits

Recently Grifols S-A has paid out, on average, around 15.88% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.37% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Grifols S-A shareholders could enjoy a 2.37% return on their shares, in the form of dividend payments. In Grifols S-A's case, that would currently equate to about $0.466 per share.

While Grifols S-A's payout ratio might seem low, this can signify that Grifols S-A is investing more in its future growth.

Grifols S-A's most recent dividend payout was on 8 November 2020. The latest dividend was paid out to all shareholders who bought their shares by 29 October 2020 (the "ex-dividend date").

Have Grifols S-A's shares ever split?

Grifols S-A's shares were split on a 2:1 basis on 3 January 2016. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Grifols S-A shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Grifols S-A shares which in turn could have impacted Grifols S-A's share price.

Grifols S-A share price volatility

Over the last 12 months, Grifols S-A's shares have ranged in value from as little as $14.81 up to $21.6186. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Grifols S-A's is 0.0748. This would suggest that Grifols S-A's shares are less volatile than average (for this exchange).

Grifols S-A overview

Grifols, S. A. engages in the procurement, manufacture, preparation, and sale of therapeutic products primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others segments. The Bioscience segment produces plasma-derived medicines for the treatment of rare, chronic, and life-threatening conditions. It offers intravenous immunoglobin, albumin, alpha-1-antitrypsin, factor VIII, antithrombin, and other specialty hyperimmune immunoglobulins. The Hospital segment offers non-biological pharmaceutical products and medical supplies for hospital pharmacy, such as intravenous solutions, pharmatech solutions, clinical nutrition products, and medical devices for interventional therapy.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site